Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03795168 · ClinicalTrials.gov registry record · NA
Transcranial Vibrating System for Improving Vestibular Physical Therapy
A NA study, sponsored by Otolith Labs.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03795168: Clinical Trial NA study, sponsored by Otolith Labs.
NCT03795168 is a NA study that was terminated before completion, run by Otolith Labs. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03795168, a NA study, was terminated before completion, sponsored by Otolith Labs.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This research study aims to determine whether low-frequency transcranial vibrations can act as a possible treatment for the dizziness and nausea often associated with vestibular physical therapy.
Primary Outcome
The participants will perform vestibular physical therapy exercises for 30 minutes unless their dizziness symptoms prevend them to finish. The change in vestibular physical therapy exercises they can perform will be recorded by the investigator. This value will be recorded immediately after they finish their physical therapy exercises.
Interventions
- DEVICE Transcranial vibrating system
- DEVICE Transcranial vibrating system sham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2019-04-01 |
| Phase | NA |
Why NCT03795168 stopped before completion
NCT03795168 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Transcranial vibrating system is the first listed.
NCT03795168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03795168 about?
NCT03795168 is a clinical study titled "Transcranial Vibrating System for Improving Vestibular Physical Therapy". This research study aims to determine whether low-frequency transcranial vibrations can act as a possible treatment for the dizziness and nausea often associated with vestibular physical therapy.
What is the current status of trial NCT03795168?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2019-01-01. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT03795168?
The interventions under investigation include: Transcranial vibrating system (DEVICE), Transcranial vibrating system sham (DEVICE).
Who is sponsoring clinical trial NCT03795168?
This trial is sponsored by Otolith Labs, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03795168's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI